Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2019

Filed with the SEC on Mar 18, 2019 and accepted by EDGAR at Mar 18, 2019, 17:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2018-11-01 to 2019-01-31$3.4mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2018-05-01 to 2019-01-31$10.0mus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2018-11-01 to 2019-01-31$1.3mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2018-05-01 to 2019-01-31$3.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-11-01 to 2019-01-31−$370.0kus-gaap:OperatingIncomeLoss
Operating income9 months2018-05-01 to 2019-01-31$386.0kus-gaap:OperatingIncomeLoss
Income tax3 months2018-11-01 to 2019-01-31$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2018-05-01 to 2019-01-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-11-01 to 2019-01-31−$369.0kus-gaap:NetIncomeLoss
Net income9 months2018-05-01 to 2019-01-31$381.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2018-11-01 to 2019-01-31−$0.03us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2018-05-01 to 2019-01-31$0.03us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-11-01 to 2019-01-31−$0.03us-gaap:EarningsPerShareBasic
Basic EPS9 months2018-05-01 to 2019-01-31$0.03us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-11-01 to 2019-01-3111,508,180 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2018-05-01 to 2019-01-3113,909,063 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2018-05-01 to 2019-01-31$1.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2018-05-01 to 2019-01-31$693.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-01-31$3.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-01-31$7.5mus-gaap:AssetsCurrent
Total assetsAt period end2019-01-31$10.9mus-gaap:Assets
Current liabilitiesAt period end2019-01-31$7.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-01-31$8.6mus-gaap:Liabilities
Shareholders' equityAt period end2019-01-31$2.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-19-003086. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.